With the rapidly aging population, frailty, characterized by an increased risk of adverse
outcomes, has become a major public health problem globally. Several frailty guidelines or …

Multiple myeloma (MM) is primarily a disease of elderly patients. Geriatric aspects in the
context of MM have been poorly investigated until recently. Treatment outcomes for geriatric …

Multiple myeloma (MM) is a cancer of older adults and those who are more frail are at high
risk of poor outcomes. Current tools for identifying and categorizing frail patients are often …

Although randomized controlled trial data suggest that the more intensive triplet bortezomib-
lenalidomide-dexamethasone (VRd) is superior to the less intensive doublet lenalidomide …

Introduction Assessing frailty is integral to treatment decision-making for older adults with
acute myeloid leukemia (AML). Prior electronic frailty indices (eFI) derive from an …

Introduction Abiraterone and enzalutamide are treatments for metastatic castration-resistant
prostate cancer (mCRPC). Due to a lack of head-to-head trials, they are prescribed …

Background: Frailty is a common but complex problem in older adults. Frailty assessment
using routine clinical data has been suggested as a pragmatic approach based on …

Background Electronic frailty indices (eFIs) can expand measurement of frailty in research
and practice and have demonstrated predictive validity in associations with clinical …

PURPOSE To develop and validate natural language processing (NLP)–assisted machine
learning (ML)–based classification models to confirm diagnoses of monoclonal gammopathy …

Background We aimed to evaluate and compare the performance of multiple myeloma (MM)
selection algorithms for use in Veterans Affairs (VA) research. Methods Using the VA …